Literature DB >> 7527435

Coinfection of hepatitis C virus in patients with chronic hepatitis B infection.

S Sato1, S Fujiyama, M Tanaka, K Yamasaki, I Kuramoto, S Kawano, T Sato, K Mizuno, S Nonaka.   

Abstract

Enzyme-linked immunosorbent assays for detecting antibodies against hepatitis C virus and the polymerase chain reaction were tested in 82 chronic hepatitis B surface antigen carriers for their accuracy in diagnosing patients coinfected with hepatitis B and C viruses. To clarify the role of each virus in chronic hepatitis, serologic assays against hepatitis B virus were also tested. Thirteen (14.9%), 14 (17.1%) and 15 (18.3%) patients were anti-HCV positive using C100 (HCV1), JCC, and a second generation test (HCV2), respectively. HCV RNA was detected by polymerase chain reaction in 9 of 18 anti-HCV-positive cases. Although HCV1 assays were not sufficient, either the JCC or HCV2 assay detected all polymerase chain reaction-positive cases. Fifteen of 18 specimens that were positive in at least one of the three ELISA were seronegative for the hepatitis B e antigen. As judged by HBV DNA polymerase activity, titers of hepatitis B surface antigen and immunoglobulin A antibody against hepatitis B core antigen (IgA anti-HBc), activity of hepatitis B virus replication and immune response against hepatitis B virus in patients with coinfection was decreased to the level of hepatitis B virus asymptomatic carriers. These results show that hepatitis C virus appears to be the primary cause of active hepatitis in most patients with hepatitis B and hepatitis C virus coinfection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527435     DOI: 10.1016/s0168-8278(05)80389-7

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  40 in total

1.  The prevalence of HIV, HBV and HCV among Filipino blood donors and overseas work visa applicants.

Authors:  Yumiko Yanase; Takashi Ohida; Yoshitaka Kaneita; Dorothy May D Agdamag; Prisca Susan A Leaño; Christopher J Gill
Journal:  Bull World Health Organ       Date:  2007-02       Impact factor: 9.408

Review 2.  Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis.

Authors:  Asmaa-Ibrahim Gomaa; Shahid-A Khan; Mireille-B Toledano; Imam Waked; Simon-D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

3.  Parasite interactions in natural populations: insights from longitudinal data.

Authors:  S Telfer; R Birtles; M Bennett; X Lambin; S Paterson; M Begon
Journal:  Parasitology       Date:  2008-05-12       Impact factor: 3.234

4.  Clinical study of IgA antibody against hepatitis C virus core antigen in patients with type C chronic liver disease.

Authors:  M Tanaka; S Sato; S Fujiyama; S Kawano; Y Taura; H Chikazawa; Y Honda; J Shibata; T Sato
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

Review 5.  Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals.

Authors:  Jacinta A Holmes; Ming-Lung Yu; Raymond T Chung
Journal:  Expert Opin Drug Saf       Date:  2017-05-19       Impact factor: 4.250

Review 6.  KASL clinical practice guidelines: management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

7.  Limited hepatitis B virus replication space in the chronically hepatitis C virus-infected liver.

Authors:  S F Wieland; S Asabe; R E Engle; R H Purcell; F V Chisari
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

8.  Chronic hepatitis C increased the mortality rates of patients with hepatocellular carcinoma and diabetes mellitus in a triple hepatitis virus endemic community.

Authors:  Kuo-Chin Chang; Pei-Shan Tsai; Mei-Chin Hsu; Shu-Fen Hung; Chin-Chen Tsai; Sheng-Nan Lu
Journal:  J Gastroenterol       Date:  2010-01-07       Impact factor: 7.527

9.  Combined effect of socioeconomic status, viral hepatitis, and lifestyles on hepatocelluar carcinoma risk in Korea.

Authors:  E H Yun; M K Lim; J-K Oh; J H Park; A Shin; J Sung; E-C Park
Journal:  Br J Cancer       Date:  2010-07-20       Impact factor: 7.640

Review 10.  Hepatitis C virus superinfection in patients with chronic hepatitis B virus infection.

Authors:  Yun-Fan Liaw
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.